Search Browse Earnings

RetinalGenix Technologies Inc. — SlamSEC

RetinalGenix Technologies Inc.

OTC:RTGN

Surgical & Medical Instruments & Apparatus·PETALUMA, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$2.1M

FY 2024

EPS (Diluted)

-$0.12

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$38

FY 2023

Total Debt

—

Net Cash

$38

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—